Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$4.04 - $8.51 $70,889 - $149,324
-17,547 Closed
0 $0
Q1 2022

Aug 11, 2023

BUY
$7.6 - $11.02 $133,357 - $193,367
17,547 New
17,547 $133,000
Q1 2022

May 20, 2022

SELL
$7.6 - $11.02 $31,486 - $45,655
-4,143 Reduced 19.1%
17,547 $133,000
Q4 2021

Feb 16, 2022

BUY
$10.16 - $16.17 $4,511 - $7,179
444 Added 2.09%
21,690 $221,000
Q3 2021

Nov 12, 2021

SELL
$13.16 - $22.47 $16,607 - $28,357
-1,262 Reduced 5.61%
21,246 $285,000
Q2 2021

Aug 12, 2021

BUY
$19.57 - $26.32 $50,745 - $68,247
2,593 Added 13.02%
22,508 $494,000
Q1 2021

May 03, 2021

SELL
$17.58 - $32.59 $14,978 - $27,766
-852 Reduced 4.1%
19,915 $479,000
Q4 2020

Feb 12, 2021

BUY
$10.99 - $20.4 $2,340 - $4,345
213 Added 1.04%
20,767 $374,000
Q2 2020

Aug 10, 2020

SELL
$9.57 - $24.37 $12,967 - $33,021
-1,355 Reduced 6.18%
20,554 $497,000
Q1 2020

May 15, 2020

BUY
$9.07 - $26.32 $12,634 - $36,663
1,393 Added 6.79%
21,909 $241,000
Q4 2019

Feb 14, 2020

SELL
$20.54 - $31.0 $12,324 - $18,600
-600 Reduced 2.84%
20,516 $542,000
Q3 2019

Nov 12, 2019

SELL
$22.78 - $40.58 $2,346 - $4,179
-103 Reduced 0.49%
21,116 $717,000
Q2 2019

Aug 14, 2019

BUY
$16.03 - $31.1 $340,140 - $659,910
21,219 New
21,219 $651,000
Q4 2018

Feb 14, 2019

SELL
$16.51 - $51.33 $229,356 - $713,076
-13,892 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$43.15 - $67.97 $69,687 - $109,771
-1,615 Reduced 10.41%
13,892 $726,000
Q2 2018

Aug 14, 2018

BUY
$35.06 - $51.17 $165,027 - $240,857
4,707 Added 43.58%
15,507 $674,000
Q1 2018

May 15, 2018

BUY
$19.05 - $41.76 $72,885 - $159,773
3,826 Added 54.86%
10,800 $401,000
Q4 2017

Feb 08, 2018

BUY
$19.01 - $26.2 $1,520 - $2,096
80 Added 1.16%
6,974 $138,000
Q3 2017

Nov 14, 2017

BUY
$12.53 - $27.12 $86,381 - $186,965
6,894
6,894 $171,000

Others Institutions Holding GTHX

About G1 Therapeutics, Inc.


  • Ticker GTHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,746,800
  • Market Cap $306M
  • Description
  • G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...
More about GTHX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.